Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.55 USD | +0.36% | +0.40% | -5.14% |
Mar. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Mar. 18 | BTIG Upgrades Globus Medical to Buy From Neutral, Price Target is $60 | MT |
Financials (USD)
Sales 2024 * | 2.48B | Sales 2025 * | 2.65B | Capitalization | 6.83B |
---|---|---|---|---|---|
Net income 2024 * | 272M | Net income 2025 * | 407M | EV / Sales 2024 * | 2.38 x |
Net cash position 2024 * | 939M | Net cash position 2025 * | 1.44B | EV / Sales 2025 * | 2.03 x |
P/E ratio 2024 * |
28.8
x | P/E ratio 2025 * |
16.9
x | Employees | 5,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.18% |
Latest transcript on Globus Medical, Inc.
1 day | +0.36% | ||
1 week | +0.40% | ||
Current month | -5.76% | ||
1 month | -4.73% | ||
3 months | -5.95% | ||
6 months | +10.71% | ||
Current year | -5.14% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Scavilla
CEO | Chief Executive Officer | 59 | 15-05-03 |
David Davidar
FOU | Founder | 58 | 03-02-28 |
David Paul
FOU | Founder | 57 | 03-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Zarrilli
BRD | Director/Board Member | 62 | 19-04-30 |
Rob Douglas
BRD | Director/Board Member | 64 | 19-12-10 |
James Tobin
BRD | Director/Board Member | 79 | 15-08-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.01% | 2 M€ | +6.77% | ||
0.99% | 152 M€ | -1.84% | - | |
0.74% | 16 M€ | -8.49% | ||
0.44% | 8 M€ | +2.44% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 50.55 | +0.36% | 545,156 |
24-04-25 | 50.37 | -2.08% | 613,282 |
24-04-24 | 51.44 | +0.33% | 883,839 |
24-04-23 | 51.27 | +0.04% | 900,470 |
24-04-22 | 51.25 | +1.79% | 967,602 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.14% | 6.83B | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- GMED Stock